OECDReferencia EN/AU/PS1096548
Fiasp FlexTouch
Información oficial organizada para facilitar su consulta. La publicación de la fuente conserva la autoridad.
Identificación
Identificación del producto
- Producto
- Fiasp FlexTouch
- Identificadores oficiales
- EAN: 9324627002119
Información oficial
Riesgo y medidas
- Riesgo o peligro
- The storage instructions inside the product has incorrect labelling. The pack insert incorrectly states: ‘Do not keep the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you. The storage conditions are correctly stated on the product carton. The correct statement reads: ‘You can carry the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you. You can keep it at room temperature (not above 30°C) or in a refrigerator (2°C - 8°C) for up to 4 weeks.’ Storing the product at incorrect temperatures may result in reduced effectiveness, which may increase the risk of adverse health effects.
- Recomendaciones
- Consumers should follow the instructions on the carton which indicate you can carry the Fiasp® FlexTouch® you are using, or carrying as a spare, either below 30°C or in a refrigerator (2°C - 8°C). Consumers can obtain a current Consumer Medicine Information leaflet from a pharmacist or visit the TGA website at https://www.ebs.tga.gov.au/ For further information, contact NovoNordisk Customer Service by phone on 1800 668 626.
Información oficial
Operadores económicos
- Fabricante
- Novo Nordisk Pharmaceuticals Pty Ltd
Territorio
Geografía
- Origen
- Denmark
- Distribución
- Retirada en Australia
- País de retirada
- Australia
Procedencia y contexto
NagameAlert distingue el contenido publicado por la fuente de su organización y normalización. Los valores marcados como «NagameAlert» pertenecen a esa capa de tratamiento. Comprueba siempre medidas, alcance y actualizaciones en la publicación oficial.